

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.59220994 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.59220994 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.29366238 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.29366238 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.86053263 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.26200462 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.21137682 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.21137682 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.21137682 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.04493281 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.92006870 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.89625116 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.85231056 |
| 14 | cysteine metabolic process (GO:0006534) | 5.70410777 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51689404 |
| 16 | * urea cycle (GO:0000050) | 5.48190716 |
| 17 | * urea metabolic process (GO:0019627) | 5.48190716 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.43473653 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.42573574 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.42142881 |
| 21 | epoxygenase P450 pathway (GO:0019373) | 5.34593284 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.33584216 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.22794197 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.22573540 |
| 25 | omega-hydroxylase P450 pathway (GO:0097267) | 5.22343850 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.19832627 |
| 27 | protein carboxylation (GO:0018214) | 5.17735411 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.17735411 |
| 29 | homocysteine metabolic process (GO:0050667) | 5.11957514 |
| 30 | bile acid metabolic process (GO:0008206) | 5.04465767 |
| 31 | * nitrogen cycle metabolic process (GO:0071941) | 5.00218941 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.99737349 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.99549498 |
| 34 | lysine catabolic process (GO:0006554) | 4.92073763 |
| 35 | lysine metabolic process (GO:0006553) | 4.92073763 |
| 36 | regulation of complement activation (GO:0030449) | 4.87907048 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.86998007 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.77653141 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.77158845 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.75390026 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 4.74089849 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.71378776 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.68348330 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.68348330 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.68348330 |
| 46 | glycine metabolic process (GO:0006544) | 4.63333007 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.58740121 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.58740121 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.55142363 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.55142363 |
| 51 | phospholipid efflux (GO:0033700) | 4.50620817 |
| 52 | serine family amino acid metabolic process (GO:0009069) | 4.46792329 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 4.46122430 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.40304298 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 4.38146029 |
| 56 | L-serine metabolic process (GO:0006563) | 4.36363499 |
| 57 | cellular amino acid catabolic process (GO:0009063) | 4.35215083 |
| 58 | serine family amino acid biosynthetic process (GO:0009070) | 4.32954946 |
| 59 | coenzyme catabolic process (GO:0009109) | 4.30223957 |
| 60 | cellular glucuronidation (GO:0052695) | 4.30044758 |
| 61 | glutamate metabolic process (GO:0006536) | 4.28907760 |
| 62 | amine catabolic process (GO:0009310) | 4.27292073 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.27292073 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 4.26210309 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.26150352 |
| 66 | drug catabolic process (GO:0042737) | 4.22986851 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 4.17665843 |
| 68 | cholesterol efflux (GO:0033344) | 4.15532298 |
| 69 | ethanol oxidation (GO:0006069) | 4.13883783 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 4.12740605 |
| 71 | arginine metabolic process (GO:0006525) | 4.06249604 |
| 72 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05397385 |
| 73 | proline metabolic process (GO:0006560) | 4.03538132 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 4.01438680 |
| 75 | aldehyde catabolic process (GO:0046185) | 3.97833105 |
| 76 | nuclear pore complex assembly (GO:0051292) | 3.97037901 |
| 77 | proline biosynthetic process (GO:0006561) | 3.93595113 |
| 78 | fibrinolysis (GO:0042730) | 3.88427990 |
| 79 | regulation of bile acid biosynthetic process (GO:0070857) | 3.87293945 |
| 80 | ketone body metabolic process (GO:1902224) | 3.85862695 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83667511 |
| 82 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.83443428 |
| 83 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.83443428 |
| 84 | glucuronate metabolic process (GO:0019585) | 3.81264320 |
| 85 | uronic acid metabolic process (GO:0006063) | 3.81264320 |
| 86 | organic acid catabolic process (GO:0016054) | 3.79451661 |
| 87 | carboxylic acid catabolic process (GO:0046395) | 3.79451661 |
| 88 | acetyl-CoA metabolic process (GO:0006084) | 3.79158609 |
| 89 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79059464 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.78328148 |
| 91 | urate metabolic process (GO:0046415) | 3.76597137 |
| 92 | regulation of cholesterol homeostasis (GO:2000188) | 3.76111399 |
| 93 | sterol homeostasis (GO:0055092) | 3.73272708 |
| 94 | short-chain fatty acid metabolic process (GO:0046459) | 3.72496506 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.71889760 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.69230654 |
| 97 | tetrahydrofolate metabolic process (GO:0046653) | 3.68821635 |
| 98 | regulation of plasminogen activation (GO:0010755) | 3.68079164 |
| 99 | positive regulation of lipid catabolic process (GO:0050996) | 3.66043698 |
| 100 | complement activation, classical pathway (GO:0006958) | 3.66026040 |
| 101 | oxidative demethylation (GO:0070989) | 3.65819600 |
| 102 | drug transmembrane transport (GO:0006855) | 3.64813523 |
| 103 | cofactor catabolic process (GO:0051187) | 3.64349987 |
| 104 | protein-lipid complex assembly (GO:0065005) | 3.63058710 |
| 105 | aspartate family amino acid catabolic process (GO:0009068) | 3.63013120 |
| 106 | exogenous drug catabolic process (GO:0042738) | 3.62343655 |
| 107 | cytolysis (GO:0019835) | 3.60993542 |
| 108 | complement activation (GO:0006956) | 3.60367902 |
| 109 | protein activation cascade (GO:0072376) | 3.57877108 |
| 110 | drug metabolic process (GO:0017144) | 3.53501853 |
| 111 | nuclear pore organization (GO:0006999) | 3.51860491 |
| 112 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.48397824 |
| 113 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.45598123 |
| 114 | DNA unwinding involved in DNA replication (GO:0006268) | 3.41939346 |
| 115 | DNA strand elongation (GO:0022616) | 3.40584303 |
| 116 | ribosome assembly (GO:0042255) | 3.38285303 |
| 117 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.20531527 |
| 118 | oxaloacetate metabolic process (GO:0006107) | 3.13135244 |
| 119 | IMP biosynthetic process (GO:0006188) | 3.09572567 |
| 120 | folic acid-containing compound metabolic process (GO:0006760) | 3.00355697 |
| 121 | DNA replication initiation (GO:0006270) | 2.96541097 |
| 122 | purine nucleobase biosynthetic process (GO:0009113) | 2.91734796 |
| 123 | establishment of integrated proviral latency (GO:0075713) | 2.90420689 |
| 124 | mitotic sister chromatid segregation (GO:0000070) | 2.90390391 |
| 125 | protein complex localization (GO:0031503) | 2.90041563 |
| 126 | ethanol metabolic process (GO:0006067) | 2.85551120 |
| 127 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.85389103 |
| 128 | cellular protein complex localization (GO:0034629) | 2.84029563 |
| 129 | nucleobase biosynthetic process (GO:0046112) | 2.82878561 |
| 130 | regulation of translational fidelity (GO:0006450) | 2.81745682 |
| 131 | negative regulation of blood coagulation (GO:0030195) | 2.81474659 |
| 132 | negative regulation of hemostasis (GO:1900047) | 2.81474659 |
| 133 | IMP metabolic process (GO:0046040) | 2.80738139 |
| 134 | protein localization to chromosome, centromeric region (GO:0071459) | 2.79974979 |
| 135 | mitotic chromosome condensation (GO:0007076) | 2.77964467 |
| 136 | phenylpropanoid metabolic process (GO:0009698) | 2.76792467 |
| 137 | pore complex assembly (GO:0046931) | 2.74517453 |
| 138 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.74343920 |
| 139 | alpha-amino acid biosynthetic process (GO:1901607) | 2.74115371 |
| 140 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.72053208 |
| 141 | protein localization to kinetochore (GO:0034501) | 2.71328239 |
| 142 | telomere maintenance via recombination (GO:0000722) | 2.70089355 |
| 143 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.69802153 |
| 144 | S-adenosylmethionine metabolic process (GO:0046500) | 2.69755214 |
| 145 | mitotic metaphase plate congression (GO:0007080) | 2.68769952 |
| 146 | mitotic nuclear envelope disassembly (GO:0007077) | 2.68683224 |
| 147 | sister chromatid segregation (GO:0000819) | 2.67491792 |
| 148 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.65287064 |
| 149 | positive regulation of blood coagulation (GO:0030194) | 2.65007008 |
| 150 | positive regulation of hemostasis (GO:1900048) | 2.65007008 |
| 151 | glutamine family amino acid metabolic process (GO:0009064) | 2.63008676 |
| 152 | pteridine-containing compound metabolic process (GO:0042558) | 2.61914799 |
| 153 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.61325810 |
| 154 | mitotic recombination (GO:0006312) | 2.59276165 |
| 155 | mitotic sister chromatid cohesion (GO:0007064) | 2.57044394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.44226308 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.37282507 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.27908791 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.05453303 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52390129 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.18369542 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.13494460 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.82202784 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.10660835 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03952375 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.89098029 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.61819929 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.51724828 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.32605893 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.03062499 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.01543448 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.86742325 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.64563736 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.57742473 |
| 20 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.42558806 |
| 21 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.36545632 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.25818466 |
| 23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.25394102 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.21272958 |
| 25 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.11098988 |
| 26 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.10921579 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08339539 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07464985 |
| 29 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0132499 |
| 30 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.99938315 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.98475670 |
| 32 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.95640124 |
| 33 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92785922 |
| 34 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.91405318 |
| 35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.89393640 |
| 36 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.82512954 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.80695624 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.75942532 |
| 39 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75421961 |
| 40 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.74043030 |
| 41 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.73059397 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67926979 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63312970 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61961502 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59517279 |
| 46 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.58581838 |
| 47 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.58494921 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.51264846 |
| 49 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.49799194 |
| 50 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48915123 |
| 51 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.47488793 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.47437354 |
| 53 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.45180571 |
| 54 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.43814503 |
| 55 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.40982611 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40385536 |
| 57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.40119849 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.39550454 |
| 59 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.36637419 |
| 60 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29394807 |
| 61 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.29299410 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28763699 |
| 63 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.28238636 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26972730 |
| 65 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.25513470 |
| 66 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25013962 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24136678 |
| 68 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21731446 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21529161 |
| 70 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19902099 |
| 71 | MYC_22102868_ChIP-Seq_BL_Human | 1.19250621 |
| 72 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.19193390 |
| 73 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.18289885 |
| 74 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15771725 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15304420 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14783885 |
| 77 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.09837809 |
| 78 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.09648807 |
| 79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09505773 |
| 80 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07927027 |
| 81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05242314 |
| 82 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04091173 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02320057 |
| 84 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01457698 |
| 85 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97929232 |
| 86 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97426782 |
| 87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97369373 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97334016 |
| 89 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97207485 |
| 90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96339558 |
| 91 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94593882 |
| 92 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.94163266 |
| 93 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.93860448 |
| 94 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.93524593 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93437922 |
| 96 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92585416 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92071973 |
| 98 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92008100 |
| 99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90987411 |
| 100 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.90696735 |
| 101 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89885847 |
| 102 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88054957 |
| 103 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88050142 |
| 104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86836414 |
| 105 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.86374157 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86039001 |
| 107 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85959811 |
| 108 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.82646810 |
| 109 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82578687 |
| 110 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82369383 |
| 111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80424020 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80245913 |
| 113 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79735048 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78827477 |
| 115 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78321699 |
| 116 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77643265 |
| 117 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76063480 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72241234 |
| 119 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72112236 |
| 120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71221146 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71011164 |
| 122 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.69334786 |
| 123 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.67246803 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.65352005 |
| 125 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.64312320 |
| 126 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63334731 |
| 127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62245233 |
| 128 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62183504 |
| 129 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61897155 |
| 130 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.60733823 |
| 131 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60432470 |
| 132 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60242328 |
| 133 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59975775 |
| 134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59132302 |
| 135 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58261539 |
| 136 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56032287 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55990426 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55878543 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54998724 |
| 140 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.52418110 |
| 141 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52210312 |
| 142 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.51052631 |
| 143 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50992411 |
| 144 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.50579524 |
| 145 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.50204117 |
| 146 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49522828 |
| 147 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.48527274 |
| 148 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48289165 |
| 149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.48143298 |
| 150 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.48143298 |
| 151 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48056737 |
| 152 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47728857 |
| 153 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.47609620 |
| 154 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45787613 |
| 155 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.43846503 |
| 156 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.41885383 |
| 157 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41356720 |
| 158 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.40681129 |
| 159 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.40414660 |
| 160 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39422852 |
| 161 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.38687820 |
| 162 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38472025 |
| 163 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38460463 |
| 164 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.38325275 |
| 165 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.38231415 |
| 166 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.37518594 |
| 167 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36592457 |
| 168 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.36318711 |
| 169 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35788295 |
| 170 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34660555 |
| 171 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.34629194 |
| 172 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34453187 |
| 173 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.33914343 |
| 174 | GATA1_19941826_ChIP-Seq_K562_Human | 0.33795082 |
| 175 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33609389 |
| 176 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.33572144 |
| 177 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33140227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.21501585 |
| 2 | MP0005360_urolithiasis | 7.92419685 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.36740620 |
| 4 | MP0005365_abnormal_bile_salt | 6.10751713 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.99733554 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.35567732 |
| 7 | MP0003252_abnormal_bile_duct | 3.96463727 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.49515405 |
| 9 | MP0003693_abnormal_embryo_hatching | 3.44244568 |
| 10 | MP0009840_abnormal_foam_cell | 3.28114011 |
| 11 | MP0003111_abnormal_nucleus_morphology | 3.14272488 |
| 12 | MP0010094_abnormal_chromosome_stability | 3.09224818 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 3.04813100 |
| 14 | MP0005083_abnormal_biliary_tract | 2.91049634 |
| 15 | MP0005332_abnormal_amino_acid | 2.89186020 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.75147364 |
| 17 | MP0003195_calcinosis | 2.73143488 |
| 18 | MP0003077_abnormal_cell_cycle | 2.39501005 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.31681482 |
| 20 | MP0008057_abnormal_DNA_replication | 2.27793263 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.22830611 |
| 22 | MP0000609_abnormal_liver_physiology | 2.13543934 |
| 23 | MP0008932_abnormal_embryonic_tissue | 2.04399550 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.03679581 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 2.02809913 |
| 26 | MP0001730_embryonic_growth_arrest | 1.93502701 |
| 27 | MP0008058_abnormal_DNA_repair | 1.86227887 |
| 28 | MP0003868_abnormal_feces_composition | 1.84257400 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.80762993 |
| 30 | MP0003941_abnormal_skin_development | 1.78569694 |
| 31 | MP0008007_abnormal_cellular_replicative | 1.73098673 |
| 32 | MP0001764_abnormal_homeostasis | 1.67847180 |
| 33 | MP0005451_abnormal_body_composition | 1.64378751 |
| 34 | MP0009697_abnormal_copulation | 1.63099980 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53030970 |
| 36 | MP0010352_gastrointestinal_tract_polyps | 1.48970063 |
| 37 | MP0000350_abnormal_cell_proliferation | 1.38758255 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.38038416 |
| 39 | MP0003186_abnormal_redox_activity | 1.32818298 |
| 40 | MP0001697_abnormal_embryo_size | 1.32313603 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.29293656 |
| 42 | MP0003011_delayed_dark_adaptation | 1.28345360 |
| 43 | MP0001672_abnormal_embryogenesis/_devel | 1.27645932 |
| 44 | MP0005380_embryogenesis_phenotype | 1.27645932 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.24800362 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.22766299 |
| 47 | MP0003984_embryonic_growth_retardation | 1.21817780 |
| 48 | MP0002080_prenatal_lethality | 1.18889887 |
| 49 | MP0000598_abnormal_liver_morphology | 1.18052069 |
| 50 | MP0000537_abnormal_urethra_morphology | 1.16177587 |
| 51 | MP0002088_abnormal_embryonic_growth/wei | 1.15923647 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.15806332 |
| 53 | MP0005647_abnormal_sex_gland | 1.10146444 |
| 54 | MP0001915_intracranial_hemorrhage | 1.09954753 |
| 55 | MP0002132_abnormal_respiratory_system | 1.08954134 |
| 56 | MP0002086_abnormal_extraembryonic_tissu | 1.05188884 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.02964449 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.01474620 |
| 59 | MP0005501_abnormal_skin_physiology | 1.01254900 |
| 60 | MP0010307_abnormal_tumor_latency | 1.01179318 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 0.99514822 |
| 62 | MP0002697_abnormal_eye_size | 0.99361943 |
| 63 | MP0009764_decreased_sensitivity_to | 0.98481500 |
| 64 | MP0009763_increased_sensitivity_to | 0.97516658 |
| 65 | MP0000604_amyloidosis | 0.95368981 |
| 66 | MP0002085_abnormal_embryonic_tissue | 0.95029123 |
| 67 | MP0005408_hypopigmentation | 0.94345835 |
| 68 | MP0002254_reproductive_system_inflammat | 0.93399139 |
| 69 | MP0002084_abnormal_developmental_patter | 0.93112160 |
| 70 | MP0003786_premature_aging | 0.92987252 |
| 71 | MP0003315_abnormal_perineum_morphology | 0.90790330 |
| 72 | MP0004233_abnormal_muscle_weight | 0.88710116 |
| 73 | MP0010368_abnormal_lymphatic_system | 0.87751916 |
| 74 | MP0000313_abnormal_cell_death | 0.87085272 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 0.87035178 |
| 76 | MP0001293_anophthalmia | 0.86855500 |
| 77 | MP0005187_abnormal_penis_morphology | 0.86627713 |
| 78 | MP0009642_abnormal_blood_homeostasis | 0.85254352 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 0.84512370 |
| 80 | MP0008469_abnormal_protein_level | 0.83254249 |
| 81 | MP0002009_preneoplasia | 0.82532854 |
| 82 | MP0000358_abnormal_cell_content/ | 0.80914924 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.80223897 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.79996906 |
| 85 | MP0003890_abnormal_embryonic-extraembry | 0.78830050 |
| 86 | MP0005670_abnormal_white_adipose | 0.78248344 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.76997862 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.76709273 |
| 89 | MP0010030_abnormal_orbit_morphology | 0.74022382 |
| 90 | MP0003718_maternal_effect | 0.73798610 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 0.73720202 |
| 92 | MP0002092_abnormal_eye_morphology | 0.73565169 |
| 93 | MP0004272_abnormal_basement_membrane | 0.72952728 |
| 94 | MP0004147_increased_porphyrin_level | 0.72308132 |
| 95 | MP0005266_abnormal_metabolism | 0.71681851 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.71603607 |
| 97 | MP0004197_abnormal_fetal_growth/weight/ | 0.70489180 |
| 98 | MP0002971_abnormal_brown_adipose | 0.69418991 |
| 99 | MP0001661_extended_life_span | 0.67997873 |
| 100 | MP0001756_abnormal_urination | 0.67687040 |
| 101 | MP0009053_abnormal_anal_canal | 0.67626350 |
| 102 | MP0002876_abnormal_thyroid_physiology | 0.67345159 |
| 103 | MP0002089_abnormal_postnatal_growth/wei | 0.64585961 |
| 104 | MP0005334_abnormal_fat_pad | 0.63384624 |
| 105 | MP0000490_abnormal_crypts_of | 0.62732475 |
| 106 | MP0001727_abnormal_embryo_implantation | 0.61813845 |
| 107 | MP0000467_abnormal_esophagus_morphology | 0.61522171 |
| 108 | MP0005395_other_phenotype | 0.60090739 |
| 109 | MP0005535_abnormal_body_temperature | 0.59434813 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.58907561 |
| 111 | MP0003943_abnormal_hepatobiliary_system | 0.58307446 |
| 112 | MP0004130_abnormal_muscle_cell | 0.58255050 |
| 113 | MP0005384_cellular_phenotype | 0.57888102 |
| 114 | MP0000627_abnormal_mammary_gland | 0.57201006 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.56721618 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.56602239 |
| 117 | MP0003329_amyloid_beta_deposits | 0.51548471 |
| 118 | MP0003690_abnormal_glial_cell | 0.51460135 |
| 119 | MP0005448_abnormal_energy_balance | 0.50179113 |
| 120 | MP0004264_abnormal_extraembryonic_tissu | 0.47891498 |
| 121 | MP0002928_abnormal_bile_duct | 0.45818243 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.44638794 |
| 123 | MP0008873_increased_physiological_sensi | 0.44415477 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.43752534 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.42602125 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.41904931 |
| 127 | MP0002796_impaired_skin_barrier | 0.41117533 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.40803050 |
| 129 | MP0004043_abnormal_pH_regulation | 0.40657605 |
| 130 | MP0000579_abnormal_nail_morphology | 0.39725149 |
| 131 | MP0009672_abnormal_birth_weight | 0.39500827 |
| 132 | MP0003953_abnormal_hormone_level | 0.38679364 |
| 133 | MP0008874_decreased_physiological_sensi | 0.37094639 |
| 134 | MP0010234_abnormal_vibrissa_follicle | 0.36581506 |
| 135 | MP0002822_catalepsy | 0.36505416 |
| 136 | MP0008872_abnormal_physiological_respon | 0.36144823 |
| 137 | MP0005166_decreased_susceptibility_to | 0.35750416 |
| 138 | MP0005248_abnormal_Harderian_gland | 0.34242030 |
| 139 | MP0009115_abnormal_fat_cell | 0.33556468 |
| 140 | MP0003724_increased_susceptibility_to | 0.31696432 |
| 141 | MP0002168_other_aberrant_phenotype | 0.31187784 |
| 142 | MP0002970_abnormal_white_adipose | 0.30529385 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.30384995 |
| 144 | MP0004381_abnormal_hair_follicle | 0.30270667 |
| 145 | MP0003075_altered_response_to | 0.28810736 |
| 146 | MP0003436_decreased_susceptibility_to | 0.28128874 |
| 147 | MP0001243_abnormal_dermal_layer | 0.27991826 |
| 148 | MP0001765_abnormal_ion_homeostasis | 0.27469072 |
| 149 | MP0001881_abnormal_mammary_gland | 0.27313602 |
| 150 | MP0000427_abnormal_hair_cycle | 0.26543003 |
| 151 | MP0000249_abnormal_blood_vessel | 0.25987884 |
| 152 | MP0003699_abnormal_female_reproductive | 0.25776166 |
| 153 | MP0002135_abnormal_kidney_morphology | 0.25765164 |
| 154 | MP0002837_dystrophic_cardiac_calcinosis | 0.25264961 |
| 155 | MP0003453_abnormal_keratinocyte_physiol | 0.25063029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.36494889 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.32186852 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.19887418 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.77142808 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.54602883 |
| 6 | Xanthomatosis (HP:0000991) | 6.27448297 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.23520943 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.35879334 |
| 9 | Complement deficiency (HP:0004431) | 5.24107298 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.83487594 |
| 11 | Hyperglycinemia (HP:0002154) | 4.59931049 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.54902969 |
| 13 | * Hyperammonemia (HP:0001987) | 4.54474639 |
| 14 | Joint hemorrhage (HP:0005261) | 4.54337056 |
| 15 | Epidermoid cyst (HP:0200040) | 4.48470226 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.44627700 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39496068 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.37614460 |
| 19 | Ketosis (HP:0001946) | 4.32334654 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.31943915 |
| 21 | Hyperglycinuria (HP:0003108) | 4.31481021 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.29925958 |
| 23 | Fat malabsorption (HP:0002630) | 4.25541402 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.21485463 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.21485463 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 4.10836757 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.02855793 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.89578336 |
| 29 | Abnormality of complement system (HP:0005339) | 3.80728006 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.77703026 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.65355681 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.54303090 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.41735882 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34927732 |
| 35 | Abnormality of nucleobase metabolism (HP:0010932) | 3.31170759 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.30579297 |
| 37 | Increased serum pyruvate (HP:0003542) | 3.22983920 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.22519364 |
| 39 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.15225374 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.15133352 |
| 41 | Ketoacidosis (HP:0001993) | 3.13633974 |
| 42 | Abnormality of glycolysis (HP:0004366) | 3.12247145 |
| 43 | Steatorrhea (HP:0002570) | 3.12215782 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.99203323 |
| 45 | Chromsome breakage (HP:0040012) | 2.95702388 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 2.95328243 |
| 47 | Spontaneous abortion (HP:0005268) | 2.95175348 |
| 48 | Increased mean platelet volume (HP:0011877) | 2.91102169 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.89116921 |
| 50 | Metabolic acidosis (HP:0001942) | 2.85900861 |
| 51 | Myocardial infarction (HP:0001658) | 2.85817654 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.85267989 |
| 53 | Gout (HP:0001997) | 2.83542943 |
| 54 | Acanthocytosis (HP:0001927) | 2.73303445 |
| 55 | Skin nodule (HP:0200036) | 2.73083357 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.66860433 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66860433 |
| 58 | Spastic diplegia (HP:0001264) | 2.63083127 |
| 59 | Vascular calcification (HP:0004934) | 2.61682115 |
| 60 | * Lethargy (HP:0001254) | 2.61248799 |
| 61 | Malnutrition (HP:0004395) | 2.59787471 |
| 62 | Multiple enchondromatosis (HP:0005701) | 2.56320088 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.55801630 |
| 64 | Abnormal platelet volume (HP:0011876) | 2.47338169 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.44468907 |
| 66 | Reticulocytosis (HP:0001923) | 2.44033960 |
| 67 | Cerebral edema (HP:0002181) | 2.43210487 |
| 68 | Irritability (HP:0000737) | 2.41756626 |
| 69 | Neonatal onset (HP:0003623) | 2.39410766 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.35580854 |
| 71 | Microvesicular hepatic steatosis (HP:0001414) | 2.32381654 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.31429548 |
| 73 | Cholelithiasis (HP:0001081) | 2.30445511 |
| 74 | Glomerulonephritis (HP:0000099) | 2.26545439 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.25775638 |
| 76 | Cholecystitis (HP:0001082) | 2.25775638 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.22255451 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.21600735 |
| 79 | Pancreatitis (HP:0001733) | 2.20925894 |
| 80 | Esophageal varix (HP:0002040) | 2.20391976 |
| 81 | Mitral stenosis (HP:0001718) | 2.17445434 |
| 82 | Late onset (HP:0003584) | 2.17083619 |
| 83 | Amyloidosis (HP:0011034) | 2.14636207 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13856714 |
| 85 | Enlarged kidneys (HP:0000105) | 2.12380405 |
| 86 | Gingival bleeding (HP:0000225) | 2.09278431 |
| 87 | Alkalosis (HP:0001948) | 2.08627381 |
| 88 | Brushfield spots (HP:0001088) | 2.07381281 |
| 89 | Proximal tubulopathy (HP:0000114) | 2.07043015 |
| 90 | Poikilocytosis (HP:0004447) | 2.05573014 |
| 91 | Abnormality of the preputium (HP:0100587) | 2.05555806 |
| 92 | * Vomiting (HP:0002013) | 2.05360411 |
| 93 | Rickets (HP:0002748) | 2.03939806 |
| 94 | Thrombophlebitis (HP:0004418) | 2.02780581 |
| 95 | Hydroxyprolinuria (HP:0003080) | 2.02242467 |
| 96 | Abnormality of proline metabolism (HP:0010907) | 2.02242467 |
| 97 | Menorrhagia (HP:0000132) | 2.02133072 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01924698 |
| 99 | Hyperuricemia (HP:0002149) | 1.98483040 |
| 100 | Increased purine levels (HP:0004368) | 1.98483040 |
| 101 | Asymmetry of the thorax (HP:0001555) | 1.95873646 |
| 102 | Opisthotonus (HP:0002179) | 1.94476518 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 1.94379926 |
| 104 | Progressive external ophthalmoplegia (HP:0000590) | 1.93426706 |
| 105 | Abnormality of the gallbladder (HP:0005264) | 1.92855118 |
| 106 | Glycosuria (HP:0003076) | 1.91766148 |
| 107 | Abnormality of urine glucose concentration (HP:0011016) | 1.91766148 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91717570 |
| 109 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91688987 |
| 110 | Progressive muscle weakness (HP:0003323) | 1.91344859 |
| 111 | Abnormality of reticulocytes (HP:0004312) | 1.91180988 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 1.90262964 |
| 113 | Meckel diverticulum (HP:0002245) | 1.89786369 |
| 114 | Abnormal platelet function (HP:0011869) | 1.89783037 |
| 115 | Impaired platelet aggregation (HP:0003540) | 1.89783037 |
| 116 | Renal cortical cysts (HP:0000803) | 1.87370625 |
| 117 | Abnormality of vitamin metabolism (HP:0100508) | 1.86773908 |
| 118 | Hemorrhage of the eye (HP:0011885) | 1.85634286 |
| 119 | Abnormality of chromosome stability (HP:0003220) | 1.84805318 |
| 120 | Abnormality of the Achilles tendon (HP:0005109) | 1.79783685 |
| 121 | Abnormality of the ileum (HP:0001549) | 1.77951610 |
| 122 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.75246245 |
| 123 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.71727637 |
| 124 | Microglossia (HP:0000171) | 1.71212065 |
| 125 | Elevated alkaline phosphatase (HP:0003155) | 1.70572435 |
| 126 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.70463571 |
| 127 | Abnormality of alanine metabolism (HP:0010916) | 1.69771147 |
| 128 | Hyperalaninemia (HP:0003348) | 1.69771147 |
| 129 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.69771147 |
| 130 | Abnormality of the umbilical cord (HP:0010881) | 1.69094006 |
| 131 | Megaloblastic anemia (HP:0001889) | 1.69054793 |
| 132 | Increased nuchal translucency (HP:0010880) | 1.65296072 |
| 133 | Embryonal renal neoplasm (HP:0011794) | 1.65291130 |
| 134 | Birth length less than 3rd percentile (HP:0003561) | 1.62914145 |
| 135 | Abnormal delivery (HP:0001787) | 1.61750784 |
| 136 | Myelodysplasia (HP:0002863) | 1.60465452 |
| 137 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.59173757 |
| 138 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.59173757 |
| 139 | Single umbilical artery (HP:0001195) | 1.59173757 |
| 140 | Small intestinal stenosis (HP:0012848) | 1.57995396 |
| 141 | Duodenal stenosis (HP:0100867) | 1.57995396 |
| 142 | Neonatal hypoglycemia (HP:0001998) | 1.57640705 |
| 143 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.55257284 |
| 144 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.54492040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.24174675 |
| 2 | BUB1 | 4.40967366 |
| 3 | FGFR4 | 4.31623975 |
| 4 | ERN1 | 4.20791373 |
| 5 | SIK1 | 4.01813068 |
| 6 | ERBB4 | 3.45170012 |
| 7 | SCYL2 | 3.41250854 |
| 8 | TAOK3 | 3.30064721 |
| 9 | EIF2AK1 | 3.21641141 |
| 10 | CDC7 | 3.02079941 |
| 11 | VRK2 | 2.57516835 |
| 12 | INSRR | 2.56967489 |
| 13 | SMG1 | 2.55844617 |
| 14 | SRPK1 | 2.55764026 |
| 15 | EIF2AK3 | 2.52469009 |
| 16 | LATS1 | 2.51101574 |
| 17 | PKN2 | 2.41746347 |
| 18 | TSSK6 | 2.37815401 |
| 19 | MST1R | 2.23990358 |
| 20 | NME2 | 2.12201958 |
| 21 | MAPK11 | 2.10338052 |
| 22 | MAP2K4 | 2.08675928 |
| 23 | PLK4 | 1.99146628 |
| 24 | FRK | 1.98424663 |
| 25 | FLT3 | 1.93292920 |
| 26 | ZAK | 1.92122208 |
| 27 | BRSK2 | 1.91561353 |
| 28 | TRIB3 | 1.75482918 |
| 29 | PIK3CG | 1.74710788 |
| 30 | STK38L | 1.74535101 |
| 31 | WEE1 | 1.67834025 |
| 32 | MST4 | 1.67694999 |
| 33 | EEF2K | 1.66064606 |
| 34 | NEK9 | 1.60216255 |
| 35 | TAF1 | 1.59254995 |
| 36 | PTK6 | 1.55328753 |
| 37 | TYK2 | 1.52463265 |
| 38 | ABL2 | 1.51295758 |
| 39 | CDK7 | 1.50105137 |
| 40 | PLK3 | 1.42120572 |
| 41 | MKNK1 | 1.39984862 |
| 42 | CHEK2 | 1.38644540 |
| 43 | CDK12 | 1.35199685 |
| 44 | TRIM28 | 1.33043983 |
| 45 | VRK1 | 1.29465762 |
| 46 | PAK4 | 1.27600747 |
| 47 | GRK6 | 1.27473973 |
| 48 | RPS6KB2 | 1.26494129 |
| 49 | PRKAA2 | 1.24046161 |
| 50 | NEK2 | 1.22038244 |
| 51 | ATR | 1.21319445 |
| 52 | PLK1 | 1.20981385 |
| 53 | BRSK1 | 1.18198797 |
| 54 | JAK2 | 1.17818452 |
| 55 | MAP3K10 | 1.16399478 |
| 56 | FGFR2 | 1.15316458 |
| 57 | MAP3K7 | 1.15073497 |
| 58 | EIF2AK2 | 1.11843254 |
| 59 | AURKB | 1.08987241 |
| 60 | PINK1 | 1.08063354 |
| 61 | ERBB2 | 1.06791545 |
| 62 | KDR | 1.05148596 |
| 63 | ALK | 1.03110861 |
| 64 | DAPK2 | 1.02461509 |
| 65 | STK16 | 0.99152955 |
| 66 | MAP3K12 | 0.98908265 |
| 67 | MAP2K3 | 0.98207934 |
| 68 | TAOK2 | 0.93310533 |
| 69 | MET | 0.92760305 |
| 70 | CDK6 | 0.90650581 |
| 71 | MAP3K3 | 0.90325357 |
| 72 | AURKA | 0.89899323 |
| 73 | CHEK1 | 0.89414742 |
| 74 | PIM2 | 0.85245838 |
| 75 | MAPK4 | 0.83880893 |
| 76 | BRD4 | 0.82236898 |
| 77 | PRKAA1 | 0.80791328 |
| 78 | MAP3K11 | 0.80594619 |
| 79 | DAPK1 | 0.80422051 |
| 80 | PRKCZ | 0.79803283 |
| 81 | MAP3K6 | 0.78381351 |
| 82 | LATS2 | 0.77826754 |
| 83 | MKNK2 | 0.77530476 |
| 84 | ILK | 0.75087902 |
| 85 | ATM | 0.74613405 |
| 86 | TBK1 | 0.72508539 |
| 87 | JAK1 | 0.70699138 |
| 88 | RAF1 | 0.70302478 |
| 89 | RIPK1 | 0.70133691 |
| 90 | NME1 | 0.69101264 |
| 91 | CDK4 | 0.68706761 |
| 92 | IRAK3 | 0.68689780 |
| 93 | GSK3A | 0.68124419 |
| 94 | MAP2K6 | 0.68096497 |
| 95 | BCR | 0.67811156 |
| 96 | PDK2 | 0.66982065 |
| 97 | PRKACG | 0.66072534 |
| 98 | MUSK | 0.65708865 |
| 99 | PRPF4B | 0.64527639 |
| 100 | EPHB1 | 0.63832364 |
| 101 | DYRK1B | 0.62167590 |
| 102 | CDK8 | 0.61854189 |
| 103 | CSNK1G1 | 0.60597250 |
| 104 | MAPK12 | 0.60376595 |
| 105 | PTK2 | 0.59753809 |
| 106 | MAP3K14 | 0.57828722 |
| 107 | SGK3 | 0.57723777 |
| 108 | MAPK15 | 0.57302744 |
| 109 | NEK1 | 0.56818426 |
| 110 | SIK3 | 0.56781507 |
| 111 | CAMK2G | 0.56759283 |
| 112 | CLK1 | 0.55431095 |
| 113 | CAMK1D | 0.53603026 |
| 114 | STK3 | 0.53244826 |
| 115 | STK4 | 0.52716854 |
| 116 | RPS6KA4 | 0.51208048 |
| 117 | AKT2 | 0.51042051 |
| 118 | CSK | 0.50474583 |
| 119 | EPHA3 | 0.49697032 |
| 120 | TIE1 | 0.49142706 |
| 121 | MAP3K5 | 0.49055496 |
| 122 | CSNK2A2 | 0.48825583 |
| 123 | NTRK1 | 0.48477203 |
| 124 | MTOR | 0.48059581 |
| 125 | PDPK1 | 0.47406293 |
| 126 | CDK2 | 0.47184896 |
| 127 | CSNK2A1 | 0.46237125 |
| 128 | CDK1 | 0.45970981 |
| 129 | PDK3 | 0.45034838 |
| 130 | PDK4 | 0.45034838 |
| 131 | PDGFRA | 0.44488877 |
| 132 | TESK1 | 0.42720459 |
| 133 | PBK | 0.42571758 |
| 134 | TLK1 | 0.42381092 |
| 135 | MAP2K1 | 0.41766959 |
| 136 | MELK | 0.41462611 |
| 137 | SGK2 | 0.41214630 |
| 138 | CDK9 | 0.40166782 |
| 139 | CSNK1E | 0.39696592 |
| 140 | MAPK7 | 0.39037570 |
| 141 | FGFR3 | 0.38869644 |
| 142 | MAP3K13 | 0.38615984 |
| 143 | GRK1 | 0.38456050 |
| 144 | PRKCQ | 0.37612115 |
| 145 | CSF1R | 0.37507633 |
| 146 | IGF1R | 0.36303544 |
| 147 | RET | 0.35705991 |
| 148 | PASK | 0.35231356 |
| 149 | FGFR1 | 0.33617579 |
| 150 | BMX | 0.33537301 |
| 151 | PAK2 | 0.32926959 |
| 152 | EPHA2 | 0.32768372 |
| 153 | SGK494 | 0.32565801 |
| 154 | SGK223 | 0.32565801 |
| 155 | KSR2 | 0.32277961 |
| 156 | TGFBR2 | 0.31444878 |
| 157 | MAP2K2 | 0.30581317 |
| 158 | PRKCI | 0.30368977 |
| 159 | WNK3 | 0.29797285 |
| 160 | CSNK1G3 | 0.29299187 |
| 161 | RPS6KB1 | 0.28683336 |
| 162 | ICK | 0.28454736 |
| 163 | IKBKE | 0.28069672 |
| 164 | TTK | 0.27631620 |
| 165 | ACVR1B | 0.27585445 |
| 166 | WNK4 | 0.27005056 |
| 167 | CSNK1G2 | 0.26182111 |
| 168 | PDK1 | 0.25685385 |
| 169 | NUAK1 | 0.24864725 |
| 170 | EGFR | 0.24359599 |
| 171 | MAP3K1 | 0.24316712 |
| 172 | MAP3K8 | 0.23561384 |
| 173 | STK38 | 0.23375806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.38853145 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.66616474 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39134349 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35852991 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09085933 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68171027 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67046849 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.59891233 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59867205 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57001360 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48504694 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42094367 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 2.31390924 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26933976 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15801331 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07864394 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07501074 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96594226 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90220857 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86673423 |
| 21 | Mismatch repair_Homo sapiens_hsa03430 | 1.85172442 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85092225 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83528507 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82041320 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77997069 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.77067918 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75424129 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72383265 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71814326 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67002390 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64729669 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64680535 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64556584 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61834071 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.59043659 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.59006415 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57858798 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52463106 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.50589886 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45466269 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40520238 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.39657246 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38132368 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35076881 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35041869 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32648096 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29367015 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28929239 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.25527380 |
| 50 | Base excision repair_Homo sapiens_hsa03410 | 1.25419427 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25373834 |
| 52 | Proteasome_Homo sapiens_hsa03050 | 1.24785081 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19573950 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18155930 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16101307 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.14645888 |
| 57 | Cell cycle_Homo sapiens_hsa04110 | 1.13605444 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.10539521 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05331746 |
| 60 | RNA transport_Homo sapiens_hsa03013 | 1.04929701 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04865282 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04209611 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03623749 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00898150 |
| 65 | Spliceosome_Homo sapiens_hsa03040 | 0.98371685 |
| 66 | Homologous recombination_Homo sapiens_hsa03440 | 0.96466926 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93287764 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93129852 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91924886 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.87085534 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86038119 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.85365900 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79253973 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76145498 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75446594 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70696614 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68949895 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63543525 |
| 79 | RNA polymerase_Homo sapiens_hsa03020 | 0.61333609 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.60500302 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58813160 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50758704 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49353705 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47999338 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47239179 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.42132947 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.38467908 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.36835667 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34864825 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34159340 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32506426 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29436155 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.29393140 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24187853 |
| 95 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.22107117 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.20328412 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19679369 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.17657775 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17448681 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17243960 |
| 101 | Ribosome_Homo sapiens_hsa03010 | 0.16186883 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.13769149 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06610667 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02846431 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00601935 |
| 106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.2368238 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2278705 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2177872 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1920806 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1905206 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | -0.1871783 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1788194 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1736693 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | -0.1724718 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | -0.1646253 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1637337 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1597040 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1525947 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1470330 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1163695 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1156017 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1153918 |
| 123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0940670 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0482851 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0348629 |

